Histological and molecular types of breast cancer: is there a unifying taxonomy?

被引:308
作者
Weigelt, Britta [2 ]
Reis-Filho, Jorge S. [1 ]
机构
[1] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Mol Pathol Team, London SW3 6JB, England
[2] Lincolns Inn Fields Labs, London Res Inst, Canc Res UK, London, England
关键词
PATHOLOGICAL PROGNOSTIC-FACTORS; GENE-EXPRESSION PATTERNS; COLUMNAR CELL LESIONS; IN-SITU HYBRIDIZATION; BASAL-LIKE CARCINOMA; E-CADHERIN; DUCTAL CARCINOMAS; LOBULAR CARCINOMA; NEOADJUVANT CHEMOTHERAPY; METAPLASTIC CARCINOMA;
D O I
10.1038/nrclinonc.2009.166
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a complex and heterogeneous disease, comprising multiple tumor entities associated with distinctive histological patterns and different biological features and clinical behaviors. Microarray-based high-throughput technologies have been employed to unravel the molecular characteristics of breast cancer, including its proclivity to disseminate to distant sites, and the molecular basis for histological grade. In addition, a breast cancer molecular taxonomy based solely on transcriptomic analysis has been proposed. Most microarray studies have focused on invasive ductal carcinomas of no special type, neglecting the important information about the biology and clinical behavior of breast cancers conveyed by histological type. Histological special types of breast cancer account for up to 25% of all invasive breast cancers. The histopathological characteristics of these cancers might be driven by specific genetic alterations, providing direct evidence for genotypic-phenotypic correlations between morphological patterns and molecular changes in breast cancer. We review the historical aspects of breast cancer taxonomy, discuss the possible origins of the diversity of breast cancer and propose an approach for the identification of novel therapeutic targets on the basis of histological special types of breast cancer.
引用
收藏
页码:718 / 730
页数:13
相关论文
共 105 条
[1]   Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: Further evidence to support the concept of low nuclear grade breast neoplasia family [J].
Abdel-Fatah, Tarek M. A. ;
Powe, Desmond G. ;
Hodi, Zsolt ;
Reis-Filho, Jorge S. ;
Lee, Andrew H. S. ;
Ellis, Ian O. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (04) :513-523
[2]   High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma [J].
Abdel-Fatah, Tarek M. A. ;
Powe, Desmond G. ;
Hodi, Zsolt ;
Lee, Andrew H. S. ;
Reis-Filho, Jorge S. ;
Ellis, Ian O. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (03) :417-426
[3]   Technology Insight: tuning into the genetic orchestra using microarrays - limitations of DNA microarrays in clinical practice [J].
Abdullah-Sayani, Arnbreen ;
Bueno-de-Mesquita, Jolien M. ;
van de Vijver, Marc J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (09) :501-516
[4]  
[Anonymous], 1982, AM J CLIN PATHOL, V78, P806, DOI DOI 10.1093/AJCP/78.6.806
[5]   A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair [J].
Ashworth, Alan .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3785-3790
[6]   Polymorphous adenocarcinoma of the breast. Report of three cases [J].
Asioli, S ;
Marucci, G ;
Ficarra, G ;
Stephens, M ;
Foschini, MP ;
Ellis, IO ;
Eusebi, V .
VIRCHOWS ARCHIV, 2006, 448 (01) :29-34
[7]   KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome [J].
Azoulay, S ;
Laé, M ;
Fréneaux, P ;
Merle, S ;
Al Ghuzlan, A ;
Chnecker, C ;
Rosty, C ;
Klijanienko, J ;
Sigal-Zafrani, B ;
Salmon, R ;
Fourquet, A ;
Sastre-Garau, X ;
Vincent-Salomon, A .
MODERN PATHOLOGY, 2005, 18 (12) :1623-1631
[8]  
Azzopardi JG., 1979, PROBLEMS BREAST PATH
[9]   Will cancer stem cells provide new therapeutic targets? [J].
Behbod, F ;
Rosen, JM .
CARCINOGENESIS, 2005, 26 (04) :703-711
[10]   Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer [J].
Bernard-Pierrot, Isabelle ;
Gruel, Nadege ;
Stransky, Nicolas ;
Vincent-Salomon, Anne ;
Reyal, Fabien ;
Raynal, Virginie ;
Vallot, Celine ;
Pierron, Gaelle ;
Radvanyi, Francois ;
Delattre, Olivier .
CANCER RESEARCH, 2008, 68 (17) :7165-7175